Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is the evaluate the feasibility and safety of chemotherapy induction
treatment combined with cetuximab followed by chemoradiotherapy combined with cetuximab in
the treatment of patients with non-metastatic esophageal cancer.